Drug Shortage Report for FLULAVAL TETRA
Report ID | 94139 |
Drug Identification Number | 02420783 |
Brand name | FLULAVAL TETRA |
Common or Proper name | Quadrivalent Influenza Vaccine (Split Virion, Inactivated) |
Company Name | ID BIOMEDICAL CORPORATION OF QUEBEC |
Market Status | MARKETED |
Active Ingredient(s) | HAEMAGGLUTININ-STRAIN B HAEMAGGLUTININ-STRAIN B HAEMAGGLUTININ-STRAIN A HAEMAGGLUTININ-STRAIN A |
Strength(s) | 15MCG 15MCG 15MCG 15MCG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR |
Packaging size | 1 vial X 10 doses |
ATC code | J07BB |
ATC description | VIRAL VACCINES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2019-09-12 |
Estimated end date | Unknown |
Actual end date | 2020-07-21 |
Shortage status | Resolved |
Updated date | 2020-07-22 |
Company comments | 2019-2020 dose yield less than planned. Supply prioritized for public programs. Supply unavailable for private market. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | GlaxoSmithKline Customer Service: 1 800 387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2020-07-22 | English | Compare |
v7 | 2020-07-21 | English | Compare |
v6 | 2020-07-21 | English | Compare |
v5 | 2020-07-21 | French | Compare |
v4 | 2020-07-21 | English | Compare |
v3 | 2019-09-17 | French | Compare |
v2 | 2019-09-17 | English | Compare |
v1 | 2019-09-17 | English | Compare |
Showing 1 to 8 of 8